Natural Capsules Limited (NSE:NATCAPSUQ)
152.30
+5.30 (3.61%)
Nov 11, 2026, 1:54 PM IST
Natural Capsules Revenue
Natural Capsules had revenue of 487.12M INR in the quarter ending June 30, 2026, with 7.76% growth. This brings the company's total for the last twelve months to 1.91B, up 8.84% year-over-year. In the fiscal year ending March 31, 2026, Natural Capsules had annual revenue of 1.87B with 10.64% growth.
Revenue (ttm)
1.91B
Revenue Growth
+8.84%
P/S Ratio
0.81
Revenue / Employee
3.10M
Employees
615
Market Cap
1.59B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Natural Capsules breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.87B | 179.99M | 10.64% |
| Mar 31, 2025 | 1.69B | 137.86M | 8.87% |
| Mar 31, 2024 | 1.55B | -169.54M | -9.84% |
| Mar 31, 2023 | 1.72B | 373.09M | 27.62% |
| Mar 31, 2022 | 1.35B | 555.52M | 69.86% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sigachi Industries | 4.91B |
| Valiant Laboratories | 3.76B |
| Amanta Healthcare | 3.04B |
| Balaxi Pharmaceuticals | 2.80B |
| Alpa Laboratories | 1.11B |
| Vaishali Pharma | 1.08B |
| Par Drugs and Chemicals | 1.08B |
| Brooks Laboratories | 795.39M |